COMMUNIQUÉS West-GlobeNewswire
-
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
25/08/2026 -
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update
25/08/2026 -
10X Health Expands its Flagship Genetic Test to Now Analyze 27 Genes, Providing the Most Comprehensive Methylation Panel Available
25/08/2026 -
From Margaritas to Medicine: Construction Advances at Ally Medical ER Liberty Hill
25/08/2026 -
Investors and Entrepreneurs Agree: AI, Enterprise Demand and Investor Confidence Are Reshaping Pharma Tech, According to New McKesson Ventures Report
25/08/2026 -
Standard Process Launches GI Soothing Supplement for Dogs and Cats
25/08/2026 -
electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards
25/08/2026 -
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
25/08/2026 -
4DMT to Participate in Upcoming Investor Conferences
25/08/2026 -
Anavex Life Sciences Reports Third Fiscal Quarter 2026 Financial Results and Business Update
25/08/2026 -
Nu-Tek BioSciences participera au salon BPI East 2026 à Boston pour établir des liens entre ses nutriments pour milieux de culture sans composants d’origine animale et les stratégies de croissance de ses clients du secteur pharmaceutique
25/08/2026 -
Nu-Tek BioSciences to Attend BPI East 2026 in Boston, Connecting Animal-Free Culture Media Nutrients with Pharma Customer Growth Strategies
25/08/2026 -
Mixie Technologies, Inc. (OTC: MIXE) Portfolio Company HoloTwin Unveils TwinRuntime: Enterprise Digital Twins That Run in a Standard Web Browser, No Downloads Required
25/08/2026 -
CVRx Responds to Letter from Pointillist Family Office
25/08/2026 -
YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
25/08/2026 -
Annovis to Host Corporate Update Webinar on September 2, 2026
25/08/2026 -
Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium
25/08/2026 -
Kane Biotech’s revyve® Research Presented at Military Health System Research Symposium
25/08/2026 -
OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations
25/08/2026
Pages